Skip links

Uncategorized

Adarza BioSystems Closes on $17 Million Series C Financing

Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, Mo. manufacturing facility and fund final

Kevin Parker Featured in “Sound Waves”

The lead story in the American Institute of Ultrasound in Medicine’s November 2nd newsletter features the work of Kevin Parker, the William F May Professor of Engineering at the University of Rochester. Dr. Parker has applied 19th-Century mathematical functions to modern ultrasound to create color

FDA Gives Fast Track Status to Vaccinex Drug

By WILL ASTOR Rochester Business Journal August 8, 2016 The Food and Drug Administration has given Vaccinex Inc.’s VX15 Huntington’s disease drug fast track status. Huntington’s disease is a relatively rare affliction, affecting an estimated one in 10,000 individuals. Still, for sufferers and their families

Experimental Combination Surprises with Anti-HIV Effectiveness

A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected. The potency of the combination treatment, tested so far in mice, suggests that it would be possible to rid the body

Telephus Medical Announces Issuance of Japanese Patent for Anti-MRSA Antibodies

Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, today announced that the Japan Patent Office has issued Japanese patent number 5,837,215 covering monoclonal antibody compositions that bind and neutralize the endo-β-Nacetylglucosaminidase (Gmd) subunit of staphylococcal bifunctional